121 related articles for article (PubMed ID: 11922198)
21. Factors associated with chloroquine-induced retinopathy in rheumatic diseases.
Araiza-Casillas R; Cárdenas F; Morales Y; Cardiel MH
Lupus; 2004; 13(2):119-24. PubMed ID: 14995005
[TBL] [Abstract][Full Text] [Related]
22. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.
Lee YH; Kim YR; Ji JD; Sohn J; Song GG
J Rheumatol; 2001 Sep; 28(9):2008-11. PubMed ID: 11550967
[TBL] [Abstract][Full Text] [Related]
23. Chloroquine retinopathy.
Ganne P; Srinivasan R
JAMA Ophthalmol; 2015 May; 133(5):603-4. PubMed ID: 25974649
[No Abstract] [Full Text] [Related]
24. Influence of the TNFSF4 rs1234315 polymorphism in the susceptibility to systemic lupus erythematosus and rheumatoid arthritis.
Xu J; He Y; Wang J; Li X; Huang L; Li S; Qin X
Hum Immunol; 2019 Apr; 80(4):270-275. PubMed ID: 30468820
[TBL] [Abstract][Full Text] [Related]
25. Long-term continuation of chloroquine-induced retinal toxicity in rheumatoid arthritis despite drug cessation.
Kasturi N
Rheumatology (Oxford); 2016 Apr; 55(4):766-8. PubMed ID: 26660348
[No Abstract] [Full Text] [Related]
26. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
Aylward JM
J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
[TBL] [Abstract][Full Text] [Related]
27. Effects of chronic exposure to hydroxychloroquine or chloroquine on inner retinal structures.
Pasadhika S; Fishman GA
Eye (Lond); 2010 Feb; 24(2):340-6. PubMed ID: 19373270
[TBL] [Abstract][Full Text] [Related]
28. Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic Lupus.
Cohen S; Clowse M; Pardo P; Bhattacharya I; Menon S; Gourley I; Diehl A
Clin Ther; 2016 Jun; 38(6):1417-1434.e2. PubMed ID: 27112532
[TBL] [Abstract][Full Text] [Related]
29. Seizure associated with chloroquine therapy in a patient with systemic lupus erythematosus.
Tristano AG; Falcón L; Willson M; de Oca IM
Rheumatol Int; 2004 Sep; 24(5):315-6. PubMed ID: 14740170
[No Abstract] [Full Text] [Related]
30. Association of PDCD1 polymorphism to systemic lupus erythematosus and rheumatoid arthritis susceptibility.
do Canto LM; Farias TD; Medeiros MD; Coêlho CC; Sereia AF; de Carlos Back LK; de Mello FM; Zimmermann AF; Pereira IA; de Souza IR
Rev Bras Reumatol Engl Ed; 2016; 56(6):483-489. PubMed ID: 27914594
[TBL] [Abstract][Full Text] [Related]
31. PTPN22 polymorphisms, but not R620W, were associated with the genetic susceptibility of systemic lupus erythematosus and rheumatoid arthritis in a Chinese Han population.
Tang L; Wang Y; Zheng S; Bao M; Zhang Q; Li J
Hum Immunol; 2016 Aug; 77(8):692-698. PubMed ID: 27166176
[TBL] [Abstract][Full Text] [Related]
32. Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy.
Bernstein HN
Am J Med; 1983 Jul; 75(1A):25-34. PubMed ID: 6869408
[TBL] [Abstract][Full Text] [Related]
33. RETINOPATHY DURING CHLOROQUINE THERAPY.
Wilson W
Br J Ophthalmol; 1961 Nov; 45(11):756-8. PubMed ID: 18170732
[No Abstract] [Full Text] [Related]
34. [Ocular toxicity caused by chloroquine: case report].
Inada ET; Watanabe KP; Tanaka SG; Sakakisbara LA
Arq Bras Oftalmol; 2005; 68(3):407-9. PubMed ID: 16059580
[TBL] [Abstract][Full Text] [Related]
35. Visual function and long-term chloroquine treatment.
Bartel PR; Roux P; Robinson E; Anderson IF; Brighton SW; van der Hoven HJ; Becker PJ
S Afr Med J; 1994 Jan; 84(1):32-4. PubMed ID: 8197491
[TBL] [Abstract][Full Text] [Related]
36. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
Lyons JS; Severns ML
Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
[TBL] [Abstract][Full Text] [Related]
37. The "flying saucer" sign on spectral domain optical coherence tomography in chloroquine retinopathy.
Ascaso FJ; Rodríguez NA; San Miguel R; Huerva V
Arthritis Rheum; 2013 Sep; 65(9):2322. PubMed ID: 23817782
[No Abstract] [Full Text] [Related]
38. Chloroquine: ophthalmological safety, and clinical assessment in rheumatoid arthritis.
Percival SP; Meanock I
Br Med J; 1968 Sep; 3(5618):579-84. PubMed ID: 4875645
[TBL] [Abstract][Full Text] [Related]
39. Ophthaproblem. Chloroquine or hydroxychloroquine retinopathy.
Liu W; Sharma S
Can Fam Physician; 2005 May; 51(5):671, 679-80. PubMed ID: 15934269
[No Abstract] [Full Text] [Related]
40. Keratopathy with low dose chloroquine therapy.
Cullen AP; Chou BR
J Am Optom Assoc; 1986 May; 57(5):368-72. PubMed ID: 3711574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
